Gene Therapy Data Explorer, Q4 2026: Who Actually Gets Treated

Gene therapy works, but two high-dose AAV drugs carry most of the market, and the commercial misses came from eligible patients who never got treated. This is the interactive data behind our Gene Therapy Intelligence Report Q4 2026, as of November 2026. Click any chart, card, or row to see what sits behind it.

This is the interactive data explorer for ourGene Therapy Intelligence Report Q4 2026.